Nivagen Pharmaceuticals

Nivagen Pharmaceuticals is engaged in the development, acquisition, and sales of generic prescription drugs and over-the-counter products for the North American market. It envisions delivering high-quality products at affordable prices by leveraging global partnerships with the best FDA-approved manufacturing facilities across the world. The US generic prescription market is currently at approximately $60 billion, and over $120 billion's worth of products will be coming off of patent protection in the next 10 years. Nivagen believes that, with its strategic partnership model of global alliances with highly efficient pharmaceutical companies across the globe, it can provide cost savings to the consumer while creating value for all members of the supply chain.

Domain

nivagen.com

Employees

11-50

Last Funding

$5.0M

Founded

2008

Frequently Asked Questions

What technologies does Nivagen Pharmaceuticals use?+

Nivagen Pharmaceuticals uses 17 technologies including Contact Form 7, Slider Revolution, WordPress.

What industry is Nivagen Pharmaceuticals in?+

Nivagen Pharmaceuticals operates in the Manufacturing industry.

Where is Nivagen Pharmaceuticals based?+

Nivagen Pharmaceuticals is headquartered in United States.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026